HBIO icon

Harvard Bioscience
HBIO

Overview Fund Activity

71 hedge funds and large institutions have $74.7M invested in Harvard Bioscience in 2019 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 25 reducing their positions, and 17 closing their positions.

Holders
71
Holders Change
-7
Holders Change %
-8.97%
% of All Funds
1.56%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
10
Increased
20
Reduced
25
Closed
17
Calls
$18K
Puts
–
Net Calls
+$18K
Net Calls Change
+$15K

Top Buyers

1
ECM
1
Engine Capital Management
New York
$10.5M
2
KCM
2
Kennedy Capital Management
Missouri
$3.44M
3
GIM
3
Granahan Investment Management
Massachusetts
$5.45M
4
HP
4
Harvey Partners
New York
$2.28M
5
Assenagon Asset Management
5
Assenagon Asset Management
Luxembourg
$1.35M

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$4.05M
2
FP
2
Foundry Partners
Minnesota
$0
3
Millennium Management
3
Millennium Management
New York
$1.98M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$1.58M
5
FLAM
5
First Light Asset Management
Minnesota
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
JG
76
Jefferies Group
New York
– -$36K -18,053 Closed
Susquehanna International Group
77
Susquehanna International Group
Pennsylvania
– -$34K -16,813 Closed
USAA
78
United Services Automobile Association
Texas
– -$28K -14,248 Closed
TSS
79
Two Sigma Securities
New York
– -$25K -12,506 Closed
SG Americas Securities
80
SG Americas Securities
New York
– -$24K -11,945 Closed
ECM
81
ExodusPoint Capital Management
New York
– -$20K -10,052 Closed
Legal & General Group
82
Legal & General Group
United Kingdom
– -$10K -5,226 Closed
1 2 3
4